Richard M. Beteck is a research scientist at North-West University. He is involved in the rational design and synthesis of organic molecules as potential drug substrates against infectious disease. Much of current research is focused on the development of heterocyclic-quinolone compounds to generate novel leads in anti-TB and antimalarial chemotherapy and identify new compounds active against ESKAPE pathogens. Other areas of interest include the synthesis of compounds with anti-trypanosomal and anti-trichomonas potential. He currently supervises a team of 15 M and D researchers and three postdocs fellows.
Richard M. Beteck is a research scientist at North-West University. He is involved in the rational design and synthesis of organic molecules as potential drug substrates against infectious disease. Much of current research is focused on the development of heterocyclic-quinolone compounds to generate novel leads in anti-TB and antimalarial chemotherapy and identify new compounds active against ESKAPE pathogens. Other areas of interest include the synthesis of compounds with anti-trypanosomal and anti-trichomonas potential. He currently supervises a team of 15 M and D researchers and three postdocs fellows.